Margo Beller

Margo D. Beller's career has spanned from print magazines to daily newspapers to electronic newswires to business websites. She began as a reporter and columnist covering the insurance and banking industries during the heady days of federal deregulation. After a short stint in management, she moved into copy editing and has since enjoyed a long association with Dow Jones Newswires and, more recently, with CNBC.com and TheStreet.com.

At TheStreet.com she copy edits articles filed by contributing writers, columns and, in the evenings, the daily Mad Money recap written by Scott Rutt plus two subsidiary features based on that which run the next morning. She manages copy and edits and publishes the nightly tech roundup and any copy not handled by her afternoon colleagues. She is a go-to person for information on style.

Based in Morris County, New Jersey, her other interests are varied. She is a nature and editorial writer for several blogs, including her own.

Recent Articles By The Author

Business Borrowers Optimistic, Still Working to Reduce Risks

Business Borrowers Optimistic, Still Working to Reduce Risks

Mid-sized businesses are optimistic about the economy heading into 2016, says Tony Bedikian, managing director of Global Markets at Citizens Bank.

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Cramer will be watching for earnings from Apple, General Dynamics and Starbucks.

'Mad Money' Lightning Round: I'm Not Abandoning Rite Aid

'Mad Money' Lightning Round: I'm Not Abandoning Rite Aid

Cramer says Osiris Therapeutics is exciting, Opko Health is a buy and you can't go wrong with PPG Industries.

Jim Cramer's 'Mad Money' Recap: What Ails the Market? Drug Stocks

Jim Cramer's 'Mad Money' Recap: What Ails the Market? Drug Stocks

The drug stocks are competing with the oil patch for the prize of the worst sector in the entire market, Cramer says.

Jim Cramer's 'Mad Money' Recap: Here's Where the Bear Tide Is Turning

Jim Cramer's 'Mad Money' Recap: Here's Where the Bear Tide Is Turning

When the facts change, investors need to change their minds, Cramer says.

Jim Cramer's Top Takeaways: ConAgra, Nike, Apple, Starbucks, Wells Fargo

Jim Cramer's Top Takeaways: ConAgra, Nike, Apple, Starbucks, Wells Fargo

Cramer says ConAgra is attractive at current levels, don't buy Wells Fargo all at once, and Nike, Apple and Starbucks show the Chinese consumer is alive and buying.

Jim Cramer's Top Takeaways: Apple, Brunswick, Halyard Health

Jim Cramer's Top Takeaways: Apple, Brunswick, Halyard Health

Cramer says Apple is not for the squeamish thanks to China, Brunswick is more than just boats.

Jim Cramer's Top Takeaways: Apple, Diageo, Imax, Blue Buffalo, Freshpet, Brixmor

Jim Cramer's Top Takeaways: Apple, Diageo, Imax, Blue Buffalo, Freshpet, Brixmor

Cramer says Apple and Diageo are being tarnished by China while he wouldn't invest in Blue Buffalo or Freshpet unless they merged.

Jim Cramer's Top Takeaways: Sonic, Darden, Fitbit, Johnson Controls

Jim Cramer's Top Takeaways: Sonic, Darden, Fitbit, Johnson Controls

Cramer says Fitbit is a real company with real earnings and a bargain despite the big rally in the stock.

Jim Cramer's Top Takeaways: BioMarin, Radius Health, Allergan, Diageo, Wayfair

Jim Cramer's Top Takeaways: BioMarin, Radius Health, Allergan, Diageo, Wayfair

Cramer says BioMarin, Radius Health and Allergan are winners but stay away from Diageo.